Kristina Jones, MD
Obstetrics & Gynecology · Little Rock, ARNPI 1144632878
Payments from drug & device makers
Across 180 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$721
- Exeltis, USA Inc.$553
- Pfizer$271
- Therapeuticsmd, Inc.$197
- Organon$168
- Aroa Biosurgery Incorporated$137
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,292100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $721 |
| Exeltis, USA Inc. | 31 | $553 |
| Pfizer | 20 | $271 |
| Therapeuticsmd, Inc. | 12 | $197 |
| Organon | 9 | $168 |
| Aroa Biosurgery Incorporated | 1 | $137 |
| Merck | 6 | $96 |
| Mayne Pharma Commercial LLC | 4 | $91 |
| Millicent US Inc | 4 | $87 |
| Sumitomo Pharma America, Inc. | 4 | $81 |
| Gynesonics, Inc. | 2 | $60 |
| Mallinckrodt Hospital Products Inc. | 3 | $57 |
| Hologic Sales And Service, LLC | 1 | $57 |
| Myriad Women's Health, Inc. | 1 | $54 |
| Channel Medsystems, Inc. | 1 | $53 |
| Avion Pharmaceuticals | 3 | $52 |
| Coopersurgical, Inc. | 2 | $47 |
| Integra Lifesciences Corporation | 1 | $45 |
| Johnson & Johnson | 2 | $42 |
| Applied Medical Resources Corporation | 1 | $42 |
| Astellas Pharma US Inc | 2 | $42 |
| Myovant Sciences Inc. | 3 | $40 |
| Novartis | 2 | $38 |
| Mallinckrodt Enterprises LLC | 2 | $36 |
| Minerva Surgical, Inc | 2 | $33 |
| Smith+Nephew | 2 | $30 |
| Mylan Pharmaceuticals Inc. | 2 | $28 |
| AMAG Pharmaceuticals, Inc. | 2 | $27 |
| Acacia Pharma Inc | 1 | $23 |
| Novo Nordisk | 1 | $20 |
| Exact Sciences | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Medtronic | 1 | $15 |
| Acessa Health Inc. | 1 | $14 |
| Lupin Inc. | 1 | $13 |
How this compares
$3,303 in reported general payments places this provider in the 70th percentile of 272 obstetrics & gynecology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $314 |
| Escitalopram Oxalate | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Little Rock
- Nathan LiversLittle Rock$1.5M
- Michael CopeLittle Rock$147K
- Nirvana ManningLittle Rock$47K
- David ShenkerLittle Rock$28K
- Fred NewtonLittle Rock$27K
- Julia GoodwinLittle Rock$16K
- Richard WyattLittle Rock$14K
- Ananth RanganathanLittle Rock$11K
- Mary RacherLittle Rock$11K
- Sharai AmayaLittle Rock$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.